Sun Pharma
-
USFDA approves Sun Pharma’s generic Amphotericin B Liposome for injection
INDIA – Sun Pharmaceuticals Industries announced that one of its wholly-owned subsidiaries received final approval from the US Food and Drug Administration (FDA) for its…
-
Court orders Sun Pharma to face antitrust suit over generic drugs
USA – A Boston federal judge has ruled that Sun Pharmaceutical Industries Ltd. must face a multidistrict lawsuit over its alleged scheme to corner the…
-
India’s Sun Pharma forearming to produce Molxvir, a generic variation of Merck’s Molnupiravir
INDIA – Sun Pharmaceutical Industries, a leading pharmaceutical manufacturer in India, is gearing up to introduce Merck Sharpe Dohme and Ridgeback’s molnupiravir under the brand…
-
Race to make antiviral pill Molnupiravir heats up
INDIA – Indian antiviral manufacturers are becoming increasingly important as the first-ever COVID-19 oral treatment Molnupiravir is introduced, promising to hasten the world’s recovery from…
-
Sun Pharma introduces long-acting Chericof 12 for cough management
INDIA – Sun Pharma has launched a novel formulation antitussive syrup, Chericof 12 manufactured using Polistirex technology for sustained drug release. The syrup is the…
-
Sun Pharma ventures into Nutrition Bar segment with the launch of Revital NXT
INDIA – Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries Limited, has announced its foray into the nutrition bar segment in India with…
-
Breakthrough as phase 1 clinical malaria vaccine trial results come positive with proof to give strong lasting protection against malaria
US – The National Institute of Allergy and Infectious Diseases’ (NIAID) phase 1 clinical trials of its malaria vaccine, Sanaria (PfSPZ), have found that the…
-
Sun Pharma announces settlement of patent litigation with Celgene in US
USA – Sun Pharmaceutical Industries today announced settlement of patent litigation for generic Revlimid (lenalidomide) in the US. Lenalidomide, sold under the trade name Revlimid…